0001213900-22-041222.txt : 20220725 0001213900-22-041222.hdr.sgml : 20220725 20220725140414 ACCESSION NUMBER: 0001213900-22-041222 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220725 DATE AS OF CHANGE: 20220725 EFFECTIVENESS DATE: 20220725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cadrenal Therapeutics, Inc. CENTRAL INDEX KEY: 0001937993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880860746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-453569 FILM NUMBER: 221102785 BUSINESS ADDRESS: STREET 1: 822 A1A NORTH STREET 2: SUITE 300 CITY: PONTE VEDRA STATE: FL ZIP: 32082 BUSINESS PHONE: 904-300-0701 MAIL ADDRESS: STREET 1: 822 A1A NORTH STREET 2: SUITE 300 CITY: PONTE VEDRA STATE: FL ZIP: 32082 D 1 primary_doc.xml X0708 D LIVE 0001937993 Cadrenal Therapeutics, Inc. 822 A1A NORTH, SUITE 300 PONTE VEDRA FL FLORIDA 32082 (904) 300-0701 DELAWARE None None Corporation true 2022 Quang Pham 822 A1A North, Suite 300 Ponte Vedra FL FLORIDA 32082 Executive Officer Director Matthew Szot 822 A1A North, Suite 300 Ponte Verda FL FLORIDA 32082 Executive Officer Biotechnology Decline to Disclose 06b false 2022-07-12 false true true true 6% Convertible Note convertible into shares of common stock upon close of IPO false 25000 Boustead Securities, LLC 141391 None None 6 VENTURE, SUITE 395 IRVINE CA CALIFORNIA 92618 CA CALIFORNIA NV NEVADA false Sutter Securities Incorporated 307770 None None 6 VENTURE, SUITE 395 IRVINE CA CALIFORNIA 92618 CA CALIFORNIA NV NEVADA NY NEW YORK false 2000000 150000 1850000 false 2 76000 0 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false Cadrenal Therapeutics, Inc. /s/ Quang Pham Quang Pham Chief Executive Officer 2022-07-25